Skip to main content

Drug Interactions between Indium In-111 DTPA and Keveyis

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

dichlorphenamide indium pentetate In-111

Applies to: Keveyis (dichlorphenamide) and Indium In-111 DTPA (indium pentetate in-111)

MONITOR: Carbonic anhydrase inhibitors may cause false-positive cisternogram results with indium pentetate In-111. Carbonic anhydrase inhibition may reduce the rate of cerebrospinal fluid production by the choroid plexus and alter CSF kinetics.

MANAGEMENT: Clinicians should be aware of the possibility of a diagnostic interference.

References

  1. (2022) "Product Information. Indium In-111 DTPA (indium pentetate In-111)." GE Healthcare
  2. (2019) "Product Information. Indium (In111) DTPA (indium (111In) pentetate)." Curium Pharma UK Ltd

Switch to consumer interaction data

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.